Cargando…
Open‐Label Pilot Study of Interferon Gamma–1b in Patients With Non‐Infantile Osteopetrosis
The only treatment currently available for patients with severe infantile osteopetrosis is hematopoietic cell transplantation (HCT). HCT‐related toxicity and mortality risks typically preclude its use in non‐infantile patients, and other therapies are needed for these patients who have significant d...
Autores principales: | Nguyen, Andrew, Miller, Weston P., Gupta, Ashish, Lund, Troy C., Schiferl, Daniel, Lam, Lok Sze Kelvin, Arzumanyan, Zorayr, Orchard, Paul J., Polgreen, Lynda E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914146/ https://www.ncbi.nlm.nih.gov/pubmed/35309862 http://dx.doi.org/10.1002/jbm4.10597 |
Ejemplares similares
-
Malignant infantile osteopetrosis
por: Kumar, Kalenahalli Jagadish, et al.
Publicado: (2013) -
Diagnosis: Infantile Malign Osteopetrosis
por: Taner, Sevgin, et al.
Publicado: (2014) -
Unusual Cortical Phenotype After Hematopoietic Stem Cell Transplantation in a Patient With Osteopetrosis
por: Afshariyamchlou, Sonia, et al.
Publicado: (2022) -
A Case Report of Malignant Infantile Osteopetrosis
por: Usta, Merve, et al.
Publicado: (2012) -
Malignant Infantile Osteopetrosis: A Case Report
por: Bubshait, Dalal K, et al.
Publicado: (2020)